Primary pulmonary lymphoma in children

Xiaohui Wu1, Chunju Zhou2, Ling Jin3

  • 1Department of Respiratory Medicine, Beijing Children's Hospital, Capital Medical University, Nanlishi Road 56, Xicheng District, Beijing, China.

Insights

Primary pulmonary lymphoma (PPL) is rare in children. This study analyzes four pediatric PPL cases, highlighting clinical features and diagnostic considerations for this uncommon condition.

Area of Science:

  • Pediatric Oncology
  • Hematology
  • Pulmonology

Background:

  • Primary pulmonary lymphoma (PPL) is an exceptionally rare malignancy, particularly in pediatric populations.
  • Understanding the clinical presentation and diagnostic markers of PPL in children is crucial due to its rarity.

Purpose of the Study:

  • To analyze the clinical features of PPL in four pediatric patients.
  • To enhance the understanding and diagnostic approach to PPL in children.

Main Methods:

  • Retrospective case series analysis of four pediatric patients diagnosed with PPL.
  • Review of clinical presentations, laboratory findings, and imaging results (chest computed tomography).
  • Genetic analysis for primary immunodeficiency in relevant cases.

Main Results:

  • Four pediatric PPL cases were identified: three diffuse large B-cell lymphomas and one natural killer-T cell lymphoma.
  • Common symptoms included prolonged fever, cough, weight loss, and fatigue.
  • Radiological findings consistently showed pulmonary nodules with halo signs and air bronchograms on CT scans.
  • Two patients were diagnosed with primary immunodeficiency, suggesting a potential link.

Conclusions:

  • PPL should be considered in pediatric patients presenting with persistent fever, elevated C-reactive protein, altered white blood cell counts, and characteristic pulmonary nodules on CT.
  • The co-existence of primary immunodeficiency warrants further investigation in children diagnosed with PPL.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
292
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
945
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.5K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
611